Importer of Controlled Substances Application: SpecGx LLC, 13894 [2025-05278]
Download as PDF
<![CDATA[
13894
Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices
Endicott, D.D.S., for additional
registration in Utah. This Order is
effective April 28, 2025.
Signing Authority
This document of the Drug
Enforcement Administration was signed
on March 21, 2025, by Acting
Administrator Derek Maltz. That
document with the original signature
and date is maintained by DEA. For
administrative purposes only, and in
compliance with requirements of the
Office of the Federal Register, the
undersigned DEA Federal Register
Liaison Officer has been authorized to
sign and submit the document in
electronic format for publication, as an
official document of DEA. This
administrative process in no way alters
the legal effect of this document upon
publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug
Enforcement Administration.
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 17, 2025,
SpecGx LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147–3457,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
[FR Doc. 2025–05163 Filed 3–26–25; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA1516]
Controlled substance
Importer of Controlled Substances
Application: SpecGx LLC
Drug Enforcement
Administration Justice.
ACTION: Notice of application.
AGENCY:
SpecGx LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before April 28, 2025. Such
persons may also file a written request
for a hearing on the application on or
before April 28, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides provides the ability to
type short comments directly into the
comment field on the web page or attach
a file for lengthier comments. Please go
to https://www.regulations.gov and
follow the online instructions at that
site for submitting comments. Upon
submission of your comment, you will
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:43 Mar 26, 2025
receive a Comment Tracking Number.
Please be aware that submitted
comments are not instantaneously
available for public view on https://
www.regulations.gov. If you have
received a Comment Tracking Number,
your comment has been successfully
submitted and there is no need to
resubmit the same comment. All
requests for a hearing must be sent to (1)
Drug Enforcement administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152, and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152. All
requests for a hearing should also be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
Jkt 265001
Phenylacetone .................
Coca Leaves ...................
Thebaine ..........................
Opium, raw ......................
Poppy Straw Concentrate
Tapentadol ......................
Drug
code
Schedule
8501
9040
9333
9600
9670
9780
II
II
II
II
II
II
The company plans to import the
listed controlled substances for bulk
manufacture into Active Pharmaceutical
Ingredients for distribution to its
customers. In reference to Tapentadol
(9780) and Thebaine (9333), the
company plans to import intermediate
forms of these controlled substances for
further manufacturing prior to
distribution to its customers. No other
activities for these drugs are authorized
for this registration. Placement of these
codes onto the company’s registration
does not translate into automatic
approval of subsequent permit
applications to import controlled
substances.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Dru Administration
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025–05278 Filed 3–26–25; 8:45 am]
BILLING CODE P
OFFICE OF PERSONNEL
MANAGEMENT
Submission for Review: 3206–0206,
Evidence To Prove Dependency of a
Child, RI 25–37
Office of Personnel
Management.
ACTION: 60-Day notice and request for
comments.
AGENCY:
Office of Personnel
Management (OPM) Retirement Services
offers the general public and other
federal agencies the opportunity to
comment on the reinstatement of an
expired information collection request
(ICR), Evidence to Prove Dependency of
a Child, RI 25–37.
DATES: Comments are encouraged and
will be accepted until May 27, 2025.
ADDRESSES: You may submit comments,
identified by docket number and/or
OMB Control Number and title, by the
following method:
—Federal Rulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
All submissions received must
include the agency name and docket
number or RIN for this document. The
general policy for comments and other
submissions from members of the public
is to make these submissions available
for public viewing at https://
www.regulations.gov as they are
received without change, including any
personal identifiers or contact
information.
SUMMARY:
A
copy of this ICR with applicable
supporting documentation may be
obtained by contacting the Retirement
Services Publications Team, Office of
Personnel Management, 1900 E Street
NW, Room 3316–L, Washington, DC
20415, Attention: Cyrus S. Benson, or
sent via electronic mail to
RSPublicationsTeam@opm.gov or faxed
to (202) 606–0910 or via telephone at
(202) 936–0401.
SUPPLEMENTARY INFORMATION: As
required by the Paperwork Reduction
Act of 1995 (Pub. L. 104–13, 44 U.S.C.
chapter 35) as amended by the ClingerCohen Act (Pub. L. 104–106), OPM is
soliciting comments for this collection
(OMB No. 3206–0206).
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 90, Number 58 (Thursday, March 27, 2025)]
[Notices]
[Page 13894]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05278]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA1516]
Importer of Controlled Substances Application: SpecGx LLC
AGENCY: Drug Enforcement Administration Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: SpecGx LLC has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
April 28, 2025. Such persons may also file a written request for a
hearing on the application on or before April 28, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides provides the ability to type short comments
directly into the comment field on the web page or attach a file for
lengthier comments. Please go to https://www.regulations.gov and follow
the online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to (1) Drug Enforcement
administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152, and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 17, 2025, SpecGx LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147-3457, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Phenylacetone........................... 8501 II
Coca Leaves............................. 9040 II
Thebaine................................ 9333 II
Opium, raw.............................. 9600 II
Poppy Straw Concentrate................. 9670 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
bulk manufacture into Active Pharmaceutical Ingredients for
distribution to its customers. In reference to Tapentadol (9780) and
Thebaine (9333), the company plans to import intermediate forms of
these controlled substances for further manufacturing prior to
distribution to its customers. No other activities for these drugs are
authorized for this registration. Placement of these codes onto the
company's registration does not translate into automatic approval of
subsequent permit applications to import controlled substances.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Dru Administration approved or non-approved finished dosage
forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-05278 Filed 3-26-25; 8:45 am]
BILLING CODE P
